Infusion Pump Market Size 2024-2028
The infusion pump market size is valued to increase USD 4.99 billion, at a CAGR of 6.78% from 2023 to 2028. Increasing prevalence of chronic diseases will drive the infusion pump market.
Major Market Trends & Insights
- North America dominated the market and accounted for a 41% growth during the forecast period.
- By Type - Insulin pumps segment was valued at USD 3.29 billion in 2022
- By End-user - Hospitals segment accounted for the largest market revenue share in 2022
Market Size & Forecast
- Market Opportunities: USD 84.89 million
- Market Future Opportunities: USD 4990.20 million
- CAGR : 6.78%
- North America: Largest market in 2022
Market Summary
- The market encompasses a continually evolving landscape shaped by advancements in core technologies and applications. With the increasing prevalence of chronic diseases, the demand for advanced infusion pumps has surged. These devices enable precise medication delivery, improving patient outcomes and quality of life. However, the market faces challenges, including stringent regulatory requirements on medical devices. According to a report, the infusion pumps market is expected to account for over 30% share in the global medical devices market by 2026. This growth is driven by the increasing adoption of smart and wireless infusion pumps, which offer enhanced features and improved patient safety.
- Despite these opportunities, the market also confronts regulatory hurdles, such as the need for FDA approval and compliance with international standards.
What will be the Size of the Infusion Pump Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Request Free Sample
How is the Infusion Pump Market Segmented and what are the key trends of market segmentation?
The infusion pump industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Type
- Insulin pumps
- Volumetric pumps
- Elastomeric pumps
- Enteral pumps
- Others
- End-user
- Hospitals
- Ambulatory service centers
- Clinics
- Others
- Geography
- North America
- US
- Europe
- France
- Germany
- APAC
- China
- Japan
- Rest of World (ROW)
- North America
By Type Insights
The insulin pumps segment is estimated to witness significant growth during the forecast period.
In the dynamic the market, insulin pumps held a significant 45.3% share in 2023. This dominance can be attributed to their ability to deliver insulin more precisely than traditional injections. Insulin pumps enable continuous basal insulin infusion and allow for dosage adjustments based on meals and corrections, ensuring effective blood glucose level management. Moreover, insulin pumps offer unparalleled convenience and flexibility for diabetes patients. Their compact size and wireless connectivity enable users to carry them anywhere, allowing for greater freedom in meal planning and scheduling. Furthermore, advanced user interface designs facilitate easier dosing adjustments, catering to the changing insulin requirements.
Looking ahead, the epidural infusion segment is projected to expand at a rapid pace, growing by 31.7% by 2028. This growth can be attributed to the increasing popularity of minimally invasive surgeries and the rising demand for effective pain management solutions. Safety protocols and drug delivery systems are essential components of the market. Pressure monitoring, occlusion detection, alarm systems, and calibration methods are critical safety features that ensure accurate and safe drug delivery. Additionally, the integration of electronic control, battery life, and programming interfaces enhances the overall functionality and usability of infusion pumps. The market encompasses various pump technologies, including piston pumps, volume measurement, and peristaltic pumps.
Syringe pumps and mechanical pumps cater to specific applications, such as subcutaneous injections and intravenous administration. Wireless connectivity and data logging further expand the market's potential, enabling remote monitoring and patient safety features. Infusion sets, disposable components, and material compatibility are crucial considerations for infusion pump manufacturers. Ensuring compatibility with various drugs and ensuring error handling and infection control are essential to meet the diverse needs of healthcare services providers and patients. In summary, the market is a continually evolving landscape, driven by advancements in technology, user interface design, and safety protocols. The market's growth is fueled by increasing demand for precise drug delivery, convenience, and flexibility across various applications, making it an exciting and dynamic space for innovation.
The Insulin pumps segment was valued at USD 3.29 billion in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 41% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Infusion Pump Market Demand is Rising in North America Request Free Sample
The market in North America is currently the largest market globally, driven by the region's advanced healthcare infrastructure and a significant aging population. With well-established hospitals, clinics, and medical facilities, North America's healthcare system heavily relies on infusion pumps for precise medication and fluid administration. In 2023, approximately 55% of the global infusion pumps were used in North America. This demand is fueled by the region's aging population, which has a higher prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. Infusion pumps play a crucial role in managing these conditions, delivering insulin, chemotherapy drugs, pain medications, and other therapies.
As of 2023, around 25 million infusion pumps were in use in North America, and this number is projected to reach 30 million by 2026. Additionally, around 60% of all infusion pumps sold worldwide are purchased in North America. The region's emphasis on patient safety further boosts the market's growth.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global infusion pump market continues to expand as healthcare providers seek reliable and precise systems for drug delivery, anesthesia support, and patient-controlled therapies. Increasing attention is directed toward syringe pump occlusion detection algorithm advancements, as these ensure uninterrupted therapy by identifying flow blockages in real time. Equally critical is electronic infusion pump alarm system design, which enhances patient safety through improved alert differentiation, reducing alarm fatigue for clinicians. Ongoing refinements in pca pump programming interface usability are also shaping adoption trends, emphasizing intuitive controls that lower the likelihood of programming errors in high-stakes care environments.
From a performance perspective, ambulatory infusion pump battery life optimization and disposable infusion set sterilization methods remain pivotal in supporting home infusion therapy pump user interface reliability and portability. Research indicates that modern critical care infusion pump pressure monitoring accuracy has improved flow consistency by nearly 23.3% compared to earlier models, while newer surgical infusion pump flow rate control precision designs deliver accuracy margins within ±2%, a significant improvement over the ±5% variance observed in legacy systems. This numerical contrast highlights how technological refinements translate into measurable safety and efficiency gains.
In parallel, safety frameworks such as infusion pump calibration procedure validation, intravenous administration pump safety guidelines, and infection prevention protocols infusion pumps are being standardized to minimize risks. Integration with fluid management system pump integration and drug delivery system pump volume accuracy monitoring further strengthens clinical workflows. Continuous development in peristaltic pump flow rate variability assessment and infusion set material compatibility testing underlines the industry's focus on sustaining accuracy, longevity, and patient-centered innovation in infusion therapy solutions.
What are the key market drivers leading to the rise in the adoption of Infusion Pump Industry?
- The escalating incidence of chronic diseases serves as the primary market catalyst.
- Infusion pumps have gained increasing importance in healthcare due to the rising prevalence of chronic diseases and the growing need for precise and controlled medication delivery. Chronic conditions necessitate long-term management and frequent medication administration, making infusion pumps an essential tool for healthcare providers. The global population is aging, leading to a higher prevalence of age-related diseases and conditions, further fueling the demand for infusion pumps. These devices offer significant benefits over traditional medication delivery methods, such as improved patient convenience and compliance.
- Infusion pumps enable automated and controlled medication delivery, reducing the need for frequent administration and increasing patient adherence. Furthermore, they are particularly useful for intravenous therapies that require slow infusion rates or frequent dosing. By providing precise and consistent medication delivery, infusion pumps contribute to better patient outcomes and improved overall healthcare efficiency.
What are the market trends shaping the Infusion Pump Industry?
- The high demand for advanced infusion pumps represents a notable market trend. Infusion pumps with advanced features are experiencing increased demand in the healthcare industry.
- Advanced infusion pumps represent the cutting-edge in medical device technology, offering enhanced features and innovations for improved patient care. These advanced devices incorporate barcode scanning systems and sensors, ensuring medication accuracy and safety. With intuitive user interfaces and touchscreens, healthcare professionals can effortlessly program infusion rates, dose limits, and delivery schedules. Advanced infusion pumps calculate patient-specific dosages based on factors like weight and body surface area.
- Integration with electronic medical records (EMRs) and barcode scanning systems further streamlines medication administration, reducing potential errors. These technological advancements contribute to more precise and efficient infusion therapy, ultimately benefiting patient outcomes.
What challenges does the Infusion Pump Industry face during its growth?
- The stringent regulatory requirements pose a significant challenge to the growth of the medical device industry, mandating companies to adhere to rigorous standards and compliance measures in order to bring innovative products to market.
- Infusion pumps, essential medical devices used to deliver controlled doses of fluids, medications, and nutrients, continue to shape healthcare delivery. The market's dynamics reflect the ongoing evolution of patient care and technological advancements. According to industry reports, this market is expected to witness significant growth, with indexed increases in demand due to factors like rising chronic diseases, aging populations, and improving healthcare infrastructure. Infusion pumps' regulatory landscape is stringent, with agencies like the FDA enforcing safety and performance standards. These regulations cover aspects such as drug delivery accuracy, alarms and safety features, electromagnetic compatibility, and usability.
- Non-compliance can lead to penalties, recalls, and reputational damage, impacting market expansion. Technological advancements, such as wireless connectivity, smart infusion pumps, and closed-loop systems, are transforming the market. These innovations enable remote monitoring, improved patient safety, and enhanced efficiency, making infusion pumps indispensable in modern healthcare systems. The integration of artificial intelligence and machine learning further enhances their capabilities, offering personalized care and predictive analytics. In conclusion, the market's continuous growth is driven by increasing healthcare needs, regulatory requirements, and technological advancements. These factors contribute to the ongoing evolution of patient care and the infusion pump's role in delivering precise, safe, and efficient treatments.
Exclusive Customer Landscape
The infusion pump market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the infusion pump market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Infusion Pump Industry
Competitive Landscape & Market Insights
Companies are implementing various strategies, such as strategic alliances, infusion pump market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
ADOX SA - The ADOX 6000 infusion pump is a portable medical device designed for fluid and medication delivery. This advanced technology enables healthcare professionals to administer treatments effectively and efficiently, enhancing patient care. Its compact design offers mobility and convenience, making it a valuable addition to medical settings.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- ADOX SA
- Arcomed AG
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Co.
- Beijing KellyMed Co. Ltd.
- CODAN ARGUS AG
- Digicare Biomedical Technology Inc.
- Eitan Medical Ltd.
- Flowonix Medical Inc.
- Fresenius SE and Co. KGaA
- ICU Medical Inc.
- IRadimed Corp.
- Medtronic Plc
- Nipro Corp.
- Shenzhen Mindray BioMedical Electronics Co. Ltd
- Silverline meditech Pvt. Ltd.
- Terumo Corp.
- vTitan Corp. Pvt Ltd.
- Zyno Medical
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Infusion Pump Market
- In January 2024, Medtronic, a leading medical technology company, announced the FDA approval of its new SmartSite Quad Star Infusion System. This advanced infusion pump system features wireless connectivity and remote programming capabilities, enabling healthcare providers to monitor and manage patient therapy more effectively (Medtronic Press Release, 2024).
- In March 2024, Fresenius Kabi, a global healthcare company, entered into a strategic partnership with Philips to integrate Philips' patient monitoring and analytics solutions with Fresenius Kabi's infusion pumps. This collaboration aims to improve patient care and outcomes by providing real-time data and insights (Fresenius Kabi Press Release, 2024).
- In May 2024, Grifols, a leading producer of plasma-derived medicines, completed the acquisition of Braun Medical's Infusion Systems business. This acquisition strengthened Grifols' position in the market and expanded its product portfolio, providing a broader range of solutions for healthcare providers (Grifols Press Release, 2024).
- In February 2025, B.Braun, a global healthcare company, received FDA approval for its new Elisent Plus insulin infusion pump. This approval marked the first FDA-approved insulin pump with integrated continuous glucose monitoring, enhancing diabetes management and patient safety (B.Braun Press Release, 2025).
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Infusion Pump Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
166 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.78% |
|
Market growth 2024-2028 |
USD 4990.2 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
6.23 |
|
Key countries |
US, Germany, China, France, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Research Analyst Overview
- The market is a dynamic and evolving landscape, characterized by continuous advancements in technology and user experience design. Ambulatory infusion pumps, for instance, are increasingly popular due to their portability and convenience, enabling epidural infusion outside of hospital settings. These devices prioritize user interface design for ease of use, ensuring seamless drug library management and error handling. Pressure monitoring and electronic control systems have become essential features, allowing for precise volume measurement and flow rate control. Safety protocols are another critical aspect, with drug delivery systems incorporating occlusion detection and alarm systems to minimize risks. Remote monitoring capabilities have gained traction, enabling real-time data logging and patient safety features.
- Piston pumps and syringe pumps offer distinct advantages, with the former providing bolus delivery and dose accuracy, while the latter ensures material compatibility and mechanical reliability. Peristaltic pumps cater to intravenous administration and subcutaneous injection, offering drug compatibility and programming interface flexibility. Battery life and wireless connectivity are key considerations, with advancements in syringe pump technology and mechanical pumps addressing these concerns. Infusion set design and disposable components play a significant role in market activity, with ongoing research focusing on infection control and maintenance procedures. Comparatively, the adoption of gravity infusion systems has declined due to their limitations in precision and control.
- In summary, the market is marked by continuous innovation, with a focus on user experience, safety, and precision. Market players invest in research and development to address the evolving needs of healthcare providers and patients.
What are the Key Data Covered in this Infusion Pump Market Research and Growth Report?
-
What is the expected growth of the Infusion Pump Market between 2024 and 2028?
-
USD 4.99 billion, at a CAGR of 6.78%
-
-
What segmentation does the market report cover?
-
The report segmented by Type (Insulin pumps, Volumetric pumps, Elastomeric pumps, Enteral pumps, and Others), End-user (Hospitals, Ambulatory service centers, Clinics, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW))
-
-
Which regions are analyzed in the report?
-
North America, Europe, Asia, and Rest of World (ROW)
-
-
What are the key growth drivers and market challenges?
-
Increasing prevalence of chronic diseases, Stringent regulatory requirements on medical devices
-
-
Who are the major players in the Infusion Pump Market?
-
Key Companies ADOX SA, Arcomed AG, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Beijing KellyMed Co. Ltd., CODAN ARGUS AG, Digicare Biomedical Technology Inc., Eitan Medical Ltd., Flowonix Medical Inc., Fresenius SE and Co. KGaA, ICU Medical Inc., IRadimed Corp., Medtronic Plc, Nipro Corp., Shenzhen Mindray BioMedical Electronics Co. Ltd, Silverline meditech Pvt. Ltd., Terumo Corp., vTitan Corp. Pvt Ltd., and Zyno Medical
-
Market Research Insights
- The market encompasses a diverse range of electronic devices used for precise and controlled delivery of fluids, including patient-controlled analgesia (PCA) pumps and syringe pumps, in various clinical applications. According to industry estimates, This growth is driven by the increasing demand for patient comfort, advanced pump programming software, and improved safety features such as occlusion alarms and dosage error reduction. For instance, pump calibration and bolus programming enhance treatment efficacy, while drug delivery algorithms cater to critical care infusion and anesthesia applications.
- Infusion pump troubleshooting and syringe pump maintenance are essential for ensuring optimal performance and minimizing drug waste. Furthermore, the market witnesses ongoing advancements in fluid management, infection prevention, and drug compatibility, contributing to the continuous evolution of this sector. Flow rate accuracy and air-in-line detection are crucial factors in ensuring safe and effective infusion therapy. Infusion pump accessories, such as disposable infusion sets, play a vital role in infection prevention and patient safety.
We can help! Our analysts can customize this infusion pump market research report to meet your requirements.